Macquarie Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-28,084
| Closed | -$5.16M | – | 2704 |
|
|
2021
Q2 | $5.16M | Buy |
28,084
+168
| +0.6% | +$28.8K | ﹤0.01% | 1128 |
|
|
2021
Q1 | $4.27M | Sell |
27,916
-107,983
| -79% | -$16.7M | 0.01% | 954 |
|
|
2020
Q4 | $21.2M | Sell |
135,899
-4,090
| -3% | -$526K | 0.03% | 503 |
|
|
2020
Q3 | $16M | Buy |
139,989
+1,801
| +1% | +$194K | 0.03% | 534 |
|
|
2020
Q2 | $15.5M | Buy |
138,188
+7,318
| +6% | +$777K | 0.03% | 531 |
|
|
2020
Q1 | $11.8M | Sell |
130,870
-31,788
| -20% | -$3.12M | 0.02% | 532 |
|
|
2019
Q4 | $17.6M | Sell |
162,658
-2,520
| -2% | -$270K | 0.03% | 547 |
|
|
2019
Q3 | $16.2M | Sell |
165,178
-7,700
| -4% | -$868K | 0.03% | 495 |
|
|
2019
Q2 | $22.6M | Buy |
172,878
+15,820
| +10% | +$2.04M | 0.04% | 432 |
|
|
2019
Q1 | $21.2M | Sell |
157,058
-24,600
| -14% | -$3.06M | 0.04% | 448 |
|
|
2018
Q4 | $17.7M | Sell |
181,658
-6,821
| -4% | -$806K | 0.03% | 456 |
|
|
2018
Q3 | $26.2M | Sell |
188,479
-54,200
| -22% | -$6.8M | 0.04% | 410 |
|
|
2018
Q2 | $30.1M | Sell |
242,679
-2,670
| -1% | -$312K | 0.05% | 386 |
|
|
2018
Q1 | $27.3M | Buy |
245,349
+44,104
| +22% | +$5.27M | 0.05% | 390 |
|
|
2017
Q4 | $24.2M | Buy |
201,245
+81,651
| +68% | +$9.94M | 0.04% | 431 |
|
|
2017
Q3 | $16.8M | Sell |
119,594
-12,400
| -9% | -$1.68M | 0.03% | 488 |
|
|
2017
Q2 | $16.1M | Buy |
131,994
+57,026
| +76% | +$6.64M | 0.03% | 495 |
|
|
2017
Q1 | $9.09M | Sell |
74,968
-18,830
| -20% | -$2.43M | 0.02% | 628 |
|
|
2016
Q4 | $11.5M | Buy |
93,798
+12,639
| +16% | +$1.55M | 0.02% | 578 |
|
|
2016
Q3 | $9.95M | Sell |
81,159
-61,059
| -43% | -$7.86M | 0.02% | 600 |
|
|
2016
Q2 | $16.6M | Buy |
142,218
+34,888
| +33% | +$4.95M | 0.02% | 609 |
|
|
2016
Q1 | $14.9M | Buy |
107,330
+10,730
| +11% | +$1.58M | 0.03% | 436 |
|
|
2015
Q4 | $18.4M | Sell |
96,600
-2,300
| -2% | -$402K | 0.04% | 369 |
|
|
2015
Q3 | $15.5M | Buy |
98,900
+7,800
| +9% | +$1.42M | 0.03% | 398 |
|
|
2015
Q2 | $16.5M | Buy |
91,100
+16,197
| +22% | +$2.8M | 0.03% | 405 |
|
|
2015
Q1 | $13M | Buy |
74,903
+18,003
| +32% | +$3.26M | 0.03% | 474 |
|
|
2014
Q4 | $10.5M | Buy |
56,900
+300
| +0.5% | +$55.6K | 0.02% | 509 |
|
|
2014
Q3 | $9.38M | Buy |
56,600
+7,500
| +15% | +$1.23M | 0.02% | 521 |
|
|
2014
Q2 | $7.67M | Buy |
49,100
+7,500
| +18% | +$1.18M | 0.02% | 579 |
|
|
2014
Q1 | $6.33M | Buy |
41,600
+7,600
| +22% | +$1.21M | 0.01% | 613 |
|
|
2013
Q4 | $4.52M | Buy |
34,000
+2,600
| +8% | +$312K | 0.01% | 666 |
|
|
2013
Q3 | $3.65M | Sell |
31,400
-1,830
| -6% | -$201K | 0.01% | 700 |
|
|
2013
Q2 | $3.06M | Buy |
+33,230
| New | +$3.2M | 0.01% | 727 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM